Excessive hepatic mitochondrial TCA cycle and gluconeogenesis in humans with nonalcoholic fatty liver disease.

[1]  H. Ginsberg,et al.  Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance , 2011, Trends in Endocrinology & Metabolism.

[2]  Protocol for the measurement of fatty acid and glycerol turnover in vivo in baboons[S] , 2011, Journal of Lipid Research.

[3]  J. Brugarolas,et al.  Uncoupling hypoxia signaling from oxygen sensing in the liver results in hypoketotic hypoglycemic death , 2011, Oncogene.

[4]  H. Lardy,et al.  Paths of Carbon in Gluconeogenesis and Lipogenesis , 2011 .

[5]  P. Iozzo,et al.  Fatty acid metabolism in the liver, measured by positron emission tomography, is increased in obese individuals. , 2010, Gastroenterology.

[6]  Matthew J. Potthoff,et al.  Progressive adaptation of hepatic ketogenesis in mice fed a high-fat diet. , 2010, American journal of physiology. Endocrinology and metabolism.

[7]  Ewald Moser,et al.  Abnormal hepatic energy homeostasis in type 2 diabetes , 2009, Hepatology.

[8]  J. Patrie,et al.  Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis , 2009, Hepatology.

[9]  S. Grundy,et al.  Ethnic differences in hepatic steatosis: An insulin resistance paradox? , 2009, Hepatology.

[10]  S. Burgess,et al.  Alterations in hepatic glucose and energy metabolism as a result of calorie and carbohydrate restriction , 2008, Hepatology.

[11]  S. Kliewer,et al.  Partial Resistance to Peroxisome Proliferator–Activated Receptor-α Agonists in ZDF Rats Is Associated With Defective Hepatic Mitochondrial Metabolism , 2008, Diabetes.

[12]  F. Karpe,et al.  Adipose tissue fatty acid metabolism in insulin-resistant men , 2008, Diabetologia.

[13]  Christopher B. Newgard,et al.  Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes , 2008, Nature Reviews Molecular Cell Biology.

[14]  A. Romano,et al.  Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia–reperfusion injury , 2008, Gut.

[15]  B. S. Mohammed,et al.  Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. , 2008, Gastroenterology.

[16]  R. Rector,et al.  Nonalcoholic fatty liver disease and mitochondrial dysfunction. , 2008, World journal of gastroenterology.

[17]  G. Shulman,et al.  Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance , 2007, Proceedings of the National Academy of Sciences.

[18]  K. Petersen,et al.  Disordered lipid metabolism and the pathogenesis of insulin resistance. , 2007, Physiological reviews.

[19]  E. Oda.  Definition of metabolic syndrome. , 2007, Stroke.

[20]  E. Parks,et al.  Contributions of different fatty acid sources to very low-density lipoprotein-triacylglycerol in the fasted and fed states. , 2006, The Journal of clinical endocrinology and metabolism.

[21]  H. Mulder,et al.  Effect of murine strain on metabolic pathways of glucose production after brief or prolonged fasting. , 2005, American journal of physiology. Endocrinology and metabolism.

[22]  G. Bray,et al.  A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle. , 2005, Diabetes.

[23]  D. Pessayre,et al.  NASH: a mitochondrial disease. , 2005, Journal of hepatology.

[24]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[25]  A. Diehl,et al.  Cytokines and the pathogenesis of non-alcoholic steatohepatitis , 2005, Gut.

[26]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[27]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[28]  D. Befroy,et al.  Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease* , 2004, Journal of Biological Chemistry.

[29]  J. Horton,et al.  Molecular mediators of hepatic steatosis and liver injury. , 2004, The Journal of clinical investigation.

[30]  S. Burgess,et al.  Glucose production, gluconeogenesis, and hepatic tricarboxylic acid cycle fluxes measured by nuclear magnetic resonance analysis of a single glucose derivative. , 2004, Analytical biochemistry.

[31]  K. Petersen,et al.  Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.

[32]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  M. Beylot,et al.  Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. , 2003, Diabetes & metabolism.

[34]  J. Arenas,et al.  Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis , 2003, Hepatology.

[35]  B. Neuschwander‐Tetri,et al.  Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference , 2003, Hepatology.

[36]  J. Holst,et al.  Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis. , 2003, Diabetes.

[37]  S. Burgess,et al.  Noninvasive evaluation of liver metabolism by 2H and 13C NMR isotopomer analysis of human urine. , 2003, Analytical biochemistry.

[38]  Peter J Moate,et al.  MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. , 2003, Diabetes technology & therapeutics.

[39]  I. G. Fantus,et al.  Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-δ , 2002 .

[40]  Jing He,et al.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.

[41]  I. G. Fantus,et al.  Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta. , 2002, American journal of physiology. Endocrinology and metabolism.

[42]  A. Sherry,et al.  An integrated (2)H and (13)C NMR study of gluconeogenesis and TCA cycle flux in humans. , 2001, American journal of physiology. Endocrinology and metabolism.

[43]  J. Clore,et al.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. , 2001, Gastroenterology.

[44]  D. Breuillé,et al.  High-fat diet. , 2000 .

[45]  G. Shulman,et al.  Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. , 2000, Diabetes.

[46]  H. Cortez‐Pinto,et al.  Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. , 1999, JAMA.

[47]  G. Boden,et al.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. , 1999, The Journal of clinical investigation.

[48]  C. Day,et al.  Steatohepatitis: a tale of two "hits"? , 1998, Gastroenterology.

[49]  J. Wahren,et al.  Use of 2H2O for estimating rates of gluconeogenesis. Application to the fasted state. , 1995, The Journal of clinical investigation.

[50]  J. Wahren,et al.  14C-labeled propionate metabolism in vivo and estimates of hepatic gluconeogenesis relative to Krebs cycle flux. , 1993, The American journal of physiology.

[51]  J. Wahren,et al.  Noninvasive tracing of Krebs cycle metabolism in liver. , 1991, The Journal of biological chemistry.

[52]  M. Haymond,et al.  Validation of two-pool model for in vivo ketone body kinetics. , 1990, The American journal of physiology.

[53]  C. Cobelli,et al.  Pseudoketogenesis in hepatectomized dogs. , 1990, The American journal of physiology.

[54]  B. Landau,et al.  Pseudoketogenesis in the perfused rat heart. , 1988, The Journal of biological chemistry.

[55]  R. DeFronzo.  The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM , 1988, Diabetes.

[56]  R. DeFronzo.  Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. , 1988, Diabetes.

[57]  M. Sugden,et al.  Altered interactions between lipogenesis and fatty acid oxidation in regenerating rat liver. , 1987, The Biochemical journal.

[58]  M. Haymond,et al.  A dual-isotope technique for determination of in vivo ketone body kinetics. , 1986, The American journal of physiology.

[59]  F. Schaffner,et al.  Nonalcoholic fatty liver disease. , 1986, Progress in liver diseases.

[60]  J. McGarry,et al.  Regulation of hepatic fatty acid oxidation and ketone body production. , 1980, Annual review of biochemistry.

[61]  V. Paetkau,et al.  Paths of carbon in gluconeogenesis and lipogenesis. 3. The role and regulation of mitochondrial processes involved in supplying precursors of phosphoenolpyruvate. , 1966, The Journal of biological chemistry.